openPR Logo
Press release

Neuropathic Pain Market: Trends, Opportunities and Forecasts 2026

04-25-2017 10:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

Neuropathic Pain Market: Trends, Opportunities and Forecasts

Companies mentioned in the research report

Some of the key companies currently operating in global neuropathic pain market are Pfizer Inc., Johnson & Johnson Services Inc., Depomed Inc., Bristol-Myers Squibb and Company, Sanofi S.A., Biogen Idec Inc., Eli Lily and Company, GlaxoSmithKline PLC, and Baxter Healthcare Corporation.

Global Neuropathic Pain Market: Overview

Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also called neuroleptic medications), and antidepressants (also known as tricyclic antidepressants). Common antidepressants include amitriptyline and nortriptiline whereas valproic acid, carbamazepine, felbamate, phenytoin, and clonazepam a few of the most common anticonvulsants used for the treatment of neuropathic disorders. Tocainide or Mexiletine and Idocaine are some of the major anesthetics used to reduce neuropathic pain.

Get Sample Copy of this Report @

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19871

This report on global neuropathic pain market is a thorough study of the market in its current scenario and based on all the major factors that may impact the growth rate in the near future, it estimates the state of the market until 2024. It also notes and explores some of the trends of the market as well as highlights a few opportunities available. Among the key features of the report is the section on company profiles, wherein several key players in the global market have been analyzed for their product portfolio, market share, global presence, and recent developments including mergers, acquisitions, and collaborations.

The global market for neuropathic pain can be segmented on the basis of drug class, by indication, distribution channel, and region. By drug type, the market can be divided into tricyclic antidepressant, anticonvulsants, local anaesthesia, opioids, steroids, and others. On the basis of indication, the market can be categorized into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and others. By distribution channel, the market can be segmented into retail pharmacies, drug stores, and online pharmacies. Geographically, the report studies the opportunities available in the regions of Asia Pacific, Europe, North America, and Rest of the World.

Global Neuropathic Pain Market: Drivers and Restraints

The report observes that diabetes is the usual indication of neuropathic pain, while cancer comes second. According to the World Health Organization (WHO), 422 million people were suffering from diabetes in 2014 and this number will continue to expand in the near future, especially among the middle to low-income countries. This vast population is the primary driver in the global neuropathic pain market. Moreover, rising geriatric population, who commonly suffer from neuropathic pain, is another driver for this market. In addition to that, factors such as approval of novel treatment options, increasing demand for neuropathic pain, improving healthcare infrastructure in emerging economies, increased investment by pharmaceutical companies for research and development of improved drugs, and rising number of pain management centers will further fuel the market in positive direction. Conversely, side effects of opioids and steroids as well as cost of branded drugs are some of the factors that will hinder the growth rate of the market during the forecast period.

View Report @ http://www.transparencymarketresearch.com/neuropathic-pain-market.html

On the basis of drug class, the segment of anticonvulsants are most popular whereas the demand for tricyclic antidepressant is expected to expand at the best CAGR. By indication, diabetic neuropathy segment serves maximum demand while chemotherapy induced peripheral neuropathy is projected for most prominent growth rate. In terms of distribution channel, retail pharmacies are most profitable and is expected to remain the leading segment during the forecast period.

Global Neuropathic Pain Market: Region-wise Outlook

North America currently is the most lucrative regional market, owing to strong healthcare infrastructure and higher buying ability of the consumers. However, Asia Pacific is projected for the most significant growth rate, due to increasing prevalence of diabetes in countries such as China and India.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market: Trends, Opportunities and Forecasts 2026 here

News-ID: 514787 • Views: 377

More Releases from Transparency Market Research

Skincare Packaging Market Historical Analysis 2013–2018 with Opportunity Asses …
The global skincare packaging market is analysed by Transparency Market Research to find opportunities and analyse future trends. The report titled “Skincare Packaging Market: Global Industry Analysis, 2013 – 2018 and Opportunity Assessment, 2019 – 2027” states that the increased premiumization of skincare products and advancement in printing technology is propelling the growth of global skincare packaging market. The global skincare packaging market is projected to expand at a CAGR
HAZMAT Packaging Market is projected to expand at a CAGR of 5.8% | Leading Playe …
The global HAZMAT packaging market was valued at US$ 8.10 Billion in 2018 and is projected to expand at a CAGR of 5.8%, during the forecast period. Vendor Landscape Remains Highly Splintered in the Global Hazmat Packaging Market The key manufacturers in the HAZMAT packaging market profiled in this report include– Greif Inc., SIA Flexitanks, Hoover Ferguson Group, Schutz Container Systems, Inc., Mauser Group B.V., HINRICH Industries, Thielmann US LLC, Eagle Manufacturing
Aseptic Paper Packaging for Flat Top Carton Market is anticipated to grow at a C …
The global aseptic paper packaging for flat top carton market is estimated to be valued at US$ 7,030.0 Mn in 2019 and is anticipated to grow at a CAGR of 5.5%, to reach a market size of US$ 10,766.1 Mn by the end of the forecast period. Aseptic paper packaging for flat top carton is a paper packaging type used for manufacturing flat top carton which are also known as UHT
Global Magnesium Gluconate Market Current And Projected Industry Size In Terms O …
Magnesium sulfate is the magnesium salt of gluconic acid. Magnesium gluconate is an organic compound having chemical formula C12H22MgO14. Magnesium gluconate is a tasteless, odorless and non-flammable white solid. Magnesium is an important mineral which plays essential roles for many systems in human body, particularly in muscle, nervous system, and cellular function. Magnesium gluconate is a suitable alternative which would be used as supplement to maintain the level of magnesium

All 5 Releases


More Releases for Neuropathic

Global Neuropathic Pain Market 2018 Analysis and Forecast to 2028
Neuropathic Pain Market 2018 Wiseguyreports.Com adds “Neuropathic Pain Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “Neuropathic Pain Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Neuropathic Pain Market report also provides an in-depth survey of key players in the market which is based on the various objectives
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.
Neuropathic Pain Market to Exceed US$ 8.3 Bn in 2024
According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast
Anticonvulsants for Neuropathic Pain Market: Industry Survey and Outlook 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Neuropathic Pain Market Predicted to Rise at 5.6% CAGR
The global neuropathic pain market report profiles some of the top players operating in the global neuropathic pain market such as Baxter Healthcare Corporation, Depomed, Inc., GlaxoSmithKline PLC, Biogen Idec, Pfizer, Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Eli Lily and Company, and Bristol Myers Squibb. These companies are primarily focusing on producing improved drugs for the treatment of neuropathic pain to gain maximum share in the global neuropathic
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also